tirzepatide fda ban says shortage of GLP-1 drug is over Compounders lose battle over Eli
Description
Discover assistance programs for weight loss drugs that can make treatment more affordable
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist , primarily used to manage Type 2 diabetes and facilitate weight loss in individuals who are overweight or have obesity-related health conditions
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
Expert guidance on managing this common side effect while maintaining treatment effectiveness.
Affordab...
